CANY
NUS icon

Caxton Associates (New York)’s Nu Skin NUS Stock Holding History

Caxton Associates (New York)’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-78,736
Closed -$580K – 616
2024
Q3 		$580K Buy
78,736
+29,894
+61% +$279K 0.02% 342
2024
Q2 		$515K Buy
48,842
+29,718
+155% +$377K 0.02% 335
2024
Q1 		$264K Sell
19,124
-32,877
-63% -$513K 0.01% 398
2023
Q4 		$1.01M Buy
52,001
+5,086
+11% +$93.9K 0.05% 225
2023
Q3 		$995K Buy
+46,915
New +$1.22M 0.14% 150
2021
Q3 		– Sell
-4,784
Closed -$271K – 550
2021
Q2 		$271K Buy
+4,784
New +$272K 0.03% 342
2020
Q1 		– Sell
-11,839
Closed -$485K – 532
2019
Q4 		$485K Buy
11,839
+3,634
+44% +$148K 0.07% 178
2019
Q3 		$349K Buy
+8,205
New +$344K 0.07% 223
2019
Q2 		– Sell
-10,889
Closed -$521K – 492
2019
Q1 		$521K Buy
+10,889
New +$660K 0.08% 139
2018
Q2 		– Sell
-3,886
Closed -$286K – 451
2018
Q1 		$286K Sell
3,886
-2,126
-35% -$151K 0.01% 292
2017
Q4 		$410K Buy
+6,012
New +$389K 0.02% 303
2017
Q2 		– Sell
-6,300
Closed -$350K – 534
2017
Q1 		$350K Buy
+6,300
New +$324K ﹤0.01% 325

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Caxton Associates (New York)'s NUS Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 78,736 shares — an estimated $580K sold.

Caxton Associates (New York) first reported a position in NUS in Q1 2017 and held it in 12 quarters. The position peaked at $1.01M in Q4 2023. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 78,736 Nu Skin shares in Q4 2024, an estimated $580K.
  • Caxton Associates (New York) first reported a position in Nu Skin in Q1 2017 and held it in 12 quarters.
  • Caxton Associates (New York)'s Nu Skin position peaked at $1.01M in Q4 2023.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.